Janney Montgomery Scott LLC Sells 7,928 Shares of Sabra Healthcare REIT, Inc. $SBRA

Janney Montgomery Scott LLC lessened its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 4.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 174,400 shares of the real estate investment trust’s stock after selling 7,928 shares during the period. Janney Montgomery Scott LLC owned approximately 0.07% of Sabra Healthcare REIT worth $3,216,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of SBRA. Venture Visionary Partners LLC lifted its stake in Sabra Healthcare REIT by 2.4% in the 2nd quarter. Venture Visionary Partners LLC now owns 119,669 shares of the real estate investment trust’s stock valued at $2,207,000 after acquiring an additional 2,848 shares in the last quarter. Ballentine Partners LLC lifted its stake in Sabra Healthcare REIT by 8.7% in the 2nd quarter. Ballentine Partners LLC now owns 13,568 shares of the real estate investment trust’s stock valued at $250,000 after acquiring an additional 1,090 shares in the last quarter. GAMMA Investing LLC lifted its stake in Sabra Healthcare REIT by 28.5% in the 2nd quarter. GAMMA Investing LLC now owns 6,874 shares of the real estate investment trust’s stock valued at $127,000 after acquiring an additional 1,525 shares in the last quarter. Financiere des Professionnels Fonds d investissement inc. bought a new stake in Sabra Healthcare REIT in the 2nd quarter valued at approximately $209,000. Finally, Exchange Traded Concepts LLC lifted its stake in Sabra Healthcare REIT by 2.0% in the 2nd quarter. Exchange Traded Concepts LLC now owns 48,718 shares of the real estate investment trust’s stock valued at $898,000 after acquiring an additional 936 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Down 0.2%

SBRA stock opened at $17.98 on Thursday. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $4.31 billion, a PE ratio of 23.66, a PEG ratio of 1.21 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The business’s 50 day simple moving average is $18.77 and its 200 day simple moving average is $18.16.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.02. The business had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm’s revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.7%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 157.89%.

Wall Street Analyst Weigh In

SBRA has been the topic of several research reports. Cantor Fitzgerald initiated coverage on Sabra Healthcare REIT in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price on the stock. Scotiabank boosted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research note on Monday, June 23rd. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Wednesday, August 27th. Finally, BMO Capital Markets boosted their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research report on Monday, August 25th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.71.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.